EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis

Journal of Cell Biology

Volumn 162, Issue 4, 2003, Pages 661-671

  Vindis, Cécile ^a   Cerretti, Douglas Pat ^b   Daniel, Thomas O ^c   Huynh Do, Uyen ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b AMGEN INC   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Chemotaxis; Eph receptor; MAPK; p52Shc; Src kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADAPTOR PROTEIN; EPHRIN; EPHRIN B1; EPHRIN RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOTYROSINE; PROTEIN KINASE P60; PROTEIN P52; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL SPECIFICITY; CHEMOTAXIS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; MOUSE; NERVE FIBER; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS; TOPOGRAPHY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL MOVEMENT; CHEMOTAXIS; GRB2 ADAPTOR PROTEIN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-TYROSINE KINASES; PROTEINS; RECEPTOR, EPHB1; TYROSINE;

ANIMALIA;

EID: 0041976992     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200302073     Document Type: Article

References (32)

1. Abram, C.L., and S.A. Courtneidge. 2000. Src family tyrosine kinases and growth factor signalling. Exp. Cell Res. 254:1-13.
2. Adams, R.H., G.A. Wilkinson, C. Weiss, F. Diella, N.W. Gale, U. Deutsch, W. Risau, and R. Klein. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13:295-306.
3. Becker, E., U. Huynh-Do, S. Holland, T. Pawson, T.O. Daniel, and E.Y. Skolnik. 2000. Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation. Mol. Cell. Biol. 20:1537-1545.
4. Carter, N., T. Nakamoto, H. Hirai, and T. Hunter. 2002. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat. Cell Biol. 4:565-573.
5. Collins, L.R., W.A. Ricketts, L. Yeh, and D. Cheresh. 1999. Bifurcation of cell migratory and proliferative signalling by the adaptor protein Shc. J. Cell Biol. 147:1561-1568.
6. Daniel, T.O., E. Stein, D.P. Cerretti, P.L. St. John, B. Robert, and D.R. Abrahamson. 1996. ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int. Suppl. 57:S73-S81.
7. Davy, A., and S.M. Robbins. 2000. Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner. EMBO J. 19:5396-5405.
8. Dodelet, V.C., C. Pazzagli, A.H. Zisch, C.A. Hauser, and E.B. Pasquale. 1999. A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A. J. Biol. Chem. 274:31941-31946.
9. Eliceiri, B.P., R. Paul, P.L. Schwartzberg, J.D. Hood, J. Leng, and D.A. Cheresh. 1999. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell. 4:915-924.
10. Ellis, C., F. Kasmi, P. Ganju, E. Walls, G. Panayotou, and A.D. Reith. 1996. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn. Oncogene. 12:1727-1736.
11. Elowe, S., S.J. Holland, S. Kulkarni, and T. Pawson. 2001. Downregulation of the ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol. Cell. Biol. 21:7429-7441.
12. Han, D., T. Shen, H. Miao, B. Wang, and J. Guan. 2002. EphB1 associates with Grb7 and regulates cell migration. J. Biol. Chem. 277:45655-45661.
13. Henkemeyer, M., D. Orioli, J.T. Henderson, T.M. Saxton, S. Roder, T. Pawson, and R. Klein. 1996. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell. 86:35-46.
14. Hock, B., B. Bohme, T. Karn, S. Feller, H. Rubsamen-Waigmann, and K. Strebhardt. 1998. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions. Oncogene. 17:255-260.
15. Holland, S.J., N.W. Gale, G.D. Gish, R.A. Roth, Z. Songyang, L.C. Cantley, M. Henkemeyer, G.D. Yancopoulos, and T. Pawson. 1997. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J. 16:3877-3888.
16. Huynh-Do, U., E. Stein, A.A. Lane, H. Liu, D.P. Cerretti, and T.O. Daniel. 1999. Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through αvβ3 and α5β1 integrins. EMBO J. 18:2165-2173.
17. Huynh-Do, U., C. Vindis, H. Liu, D.P. Cerretti, J.T. McGrew, M. Enriquez, J. Chen, and T.O. Daniel. 2002. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J. Cell Sci. 115:3073-3081.
18. Miao, H., E. Burnett, M. Kinch, E. Simon, and B. Wang. 2000. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat. Cell Biol. 2:62-69.
19. Miao, H., B.R. Wei, D.M. Peehl, Q. Li, T. Alexandrou, J.R. Schelling, J.S. Rhim, J.R. Sedor, E. Burnett, and B. Wang. 2001. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat. Cell Biol. 3:527-530.
20. Palmer, A., M. Zimmer, K.S. Erdmann, V. Eulenburg, A. Porthin, R. Heumann, U. Deutsch, and R. Klein. 2002. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol. Cell. 9:725-737.
21. Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, T. Pawson, and P.G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 70:93-104.
22. Pratt, R.L., and M.S. Kinch. 2002. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade. Oncogene. 21:7690-7699.
23. Rozakis-Adcok, M., J. McGlade, G. Mbamalu, G. Pelicci, R. Daly, W. Li, A. Batzer, S. Thomas, J. Bruggeand, and P.G. Pelicci. 1992. Association of the Shc and Grb2/Sem5 SH2-containing protein is implicated in activation of the Ras pathway by tyrosine kinase. Nature. 360:689-692.
24. Songyang, Z., S.E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W.G. Haser, F. King, T. Roberts, S. Ratnofsky, and R.J. Lechleider. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:767-778.
25. Songyang, Z., B. Margolis, M. Chaudhuri, S.E. Shoelson, and L.C. Cantley. 1995. The phosphotyrosine domain of SHC recognizes tyrosine-phosphorylated NPXY motif. J. Biol. Chem. 270:14863-14866.
26. Stein, E., U. Huynh-Do, A.A. Lane, D.P. Cerretti, and T.O. Daniel. 1998a. Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase. J. Biol. Chem. 273:1303-1308.
27. Stein, E., A.A. Lane, D.P. Cerretti, H.O. Schoecklmann, A.D. Schroff, R.L. Van Etten, and T.O. Daniel. 1998b. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 12:667-678.
28. Stein, P.L., H. Vogel, and P. Soriano. 1994. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev. 8:1999-2007.
29. Takasu, M.A., M.B. Dalva, R.E. Zigmond, and M.E. Greenberg. 2002. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science. 295:491-495.
30. van der Geer, P., and T. Pawson. 1995. The PTB domain: a new protein module implicated in signal transduction. Trends Biochem. Sci. 20:277-280.
31. Wang, H.U., Z.F. Chenand, and D.J. Anderson. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93:741-753.
32. Zisch, A.H., M.S. Kalo, L.D. Chong, and E.B. Pasquale. 1998. Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region. Oncogene. 16:2657-2670.